These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 1732009)
1. Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by gamma-interferon. Niedbala MJ; Picarella MS Blood; 1992 Feb; 79(3):678-87. PubMed ID: 1732009 [TBL] [Abstract][Full Text] [Related]
2. Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator. Niedbala MJ; Stein-Picarella M Blood; 1993 May; 81(10):2608-17. PubMed ID: 7683925 [TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor regulation of endothelial cell extracellular proteolysis: the role of urokinase plasminogen activator. Niedbala MJ; Stein-Picarella M Biol Chem Hoppe Seyler; 1992 Jul; 373(7):555-66. PubMed ID: 1381189 [TBL] [Abstract][Full Text] [Related]
10. Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix. Kroon ME; Koolwijk P; van der Vecht B; van Hinsbergh VW Blood; 2000 Oct; 96(8):2775-83. PubMed ID: 11023511 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. van Hinsbergh VW; van den Berg EA; Fiers W; Dooijewaard G Blood; 1990 May; 75(10):1991-8. PubMed ID: 2140060 [TBL] [Abstract][Full Text] [Related]
12. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin. Preissner KT; Grulich-Henn J; Ehrlich HJ; Declerck P; Justus C; Collen D; Pannekoek H; Müller-Berghaus G J Biol Chem; 1990 Oct; 265(30):18490-8. PubMed ID: 1698787 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Allan EH; Martin TJ J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231 [TBL] [Abstract][Full Text] [Related]
15. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression. Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076 [TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma modulates the fibrinolytic response in cultured human endothelial cells. Arnman V; Stemme S; Rymo L; Risberg B Thromb Res; 1995 Mar; 77(5):431-40. PubMed ID: 7778058 [TBL] [Abstract][Full Text] [Related]
17. Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes. Chavakis T; Kanse SM; Yutzy B; Lijnen HR; Preissner KT Blood; 1998 Apr; 91(7):2305-12. PubMed ID: 9516128 [TBL] [Abstract][Full Text] [Related]
18. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori. Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653 [TBL] [Abstract][Full Text] [Related]